** Credit Suisse cuts Swiss high-precision delivery devices
manufacturer Medmix MEDX.S to "neutral" from "outperform"
after the Polish government reconfirmed sanctions on Medmix
Poland, triggering the group to relocate production to other
sites urn:newsml:reuters.com:*:nL5N2X81J1
** The brokerage adopts cautious stance on the near-term
impact of the sanctions, removing the output from Medmix's
Wroclaw plant from its 2022-2023 estimates
** It also lowers 2022-2024 sales estimates by around 12%
and adj. EPS by around 26%
** The broker flags increased forecasting risks from
customer retention and timely availability of personnel and
equipment at new sites
(Reporting by Anastasiia Kozlova)
((Anastasiia.Kozlova@thomsonreuters.com))